Sleep Apnea Devices Market Is Projected to Register a CAGR of 7.8% During The Forecast Period 2022 - 2032: FMI

By 2032, The Sleep Apnea Devices Market to Be Worth US$ 14.86 Bn; Popularity of Home Sleep Apnea Tests to Boost Adoption

Valley Cottage, New York, UNITED STATES


DUBAI, United Arab Emirates, March 14, 2022 (GLOBE NEWSWIRE) -- The expanding prevalence of sleep apnea and related co-morbidities and expanding knowledge about sleep disorders are among the primary drivers driving overall sleep apnea devices market expansion.

Technological improvement is expected to boost the sleep apnea devices market growth during the forecast period. These improvements in oral appliances, oxygen devices, and actigraphy systems have improved sleep disorders' treatment results and success rate.

Players in the sleep apnea devices market are concentrating their efforts on research and development in order to create novel technology.

Attributes Details 
Sleep Apnea Devices Market CAGR (2022 – 2032) 7.8%
Sleep Apnea Devices Market (2026) US$ 9.5 Bn 
Sleep Apnea Devices Market Attraction Rising adoption of these devices in home care settings due to increased pressure on healthcare facilities to treat sleep disorders effectively without having to visit hospitals to boost market growth.

Newly released lightweight, portable sleep apnea solutions are integrated with pressure compensating sensors that can correct for altitude-related reductions in atmospheric pressure, enhancing their acceptance. Sleep apnea devices are becoming increasingly popular since they provide patients with more options and freedom.

To remain ‘ahead’ of your competitors, request for a sample @ futuremarketinsights.com/reports/sample/rep-gb-14383

Thus, the adoption of technology-enabled sleep apnea devices for both diagnostic and therapeutic reasons in various sleep disorders is expected to skyrocket in the future years.

One of the key challenges impeding the adoption of sleep apnea devices is a lack of commitment to sleep apnea therapy. Positive airway pressure sleep apnea devices are highly recommended for treating a variety of sleep disorders. Despite their great effectiveness, these devices' action efficacy is limited in certain circumstances due to the fact that they require correct and frequent usage as well as ongoing medical monitoring.

In the medium term, this lack of adherence will be a key impediment to the expansion of the sleep apnea equipmenmarket. However, in the long run, it will have little influence because sleep apnea devices manufacturers are focusing on making their sleep apnea devices more technologically sophisticated and lowering the difficulties associated with their adherence to sleep apnea therapy.

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-14383

The increased incidence of sleep disorders and related co-morbidities is predicted to considerably enhance sleep apnea devices market revenue.

The rapidly rising senior population suffering from sleep apnea and related health concerns have accelerated the need for sleep disorders diagnosis and treatment, which has favourably impacted the sleep apnea devices market revenue.

Key Takeaways:

  • By type, therapeutic devices account for the majority of the market for sleep apnea devices owing to the increasing adoption of sleep apnea therapeutic devices and improving reimbursement scenarios for these devices.
  • By end use, the home care settings segment is expected to grow at the fastest CAGR due to increasing patient and insurance company preference for home sleep testing, as well as a favourable reimbursement scenario for home sleep testing.
  • Due to the rising prevalence of elderly people with chronic diseases such as diabetes and obesity, the geriatric segment is expected to dominate the sleep apnea devices market, thereby spiking the sales of sleep apnea devices.
  • The direct tender segment is expected to dominate the global sleep apnea devices market since it provides high-quality and easily accessible sleep apnea devices to hospitals, diagnostic centers, ambulatory care centers, and specialty care centers.
  • During the forecast period, Asia Pacific is expected to advance at a rapid pace and experience huge demand for sleep apnea devices on account rising elderly population and an increase in the prevalence of lifestyle illnesses.

"North America is projected to be at the forefront of the sleep apnea devices market due to the prevalence of expanding technological advancement in the region and major market players. On account of rising healthcare costs and well-established healthcare infrastructure, the obstructive sleep apnea syndrome segment in the United States of North America is expected to hold a large sleep apnea devices market share." says an FMI analyst.

Competitive Landscape:

The major sleep apnea devices market companies providing sleep apnea devices are ResMed, Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, Koninklijke Philips N.V., BMC Medical Co., Ltd., SomnoMed, Medicom MTD Ltd, Somnowell, Fisher & Paykel Healthcare Limited Compumedics Limited.

Many product launches and agreements are also being initiated by companies around the world, which is accelerating the sleep apnea devices market opportunities.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-14383

Collaboration, award and recognition, business expansion, and joint ventures are enhancing the company market in the sleep apnea devices market, which also augurs well for the sleep apnea devices market future trends.

Some of the recent developments in the sleep apnea devices market are:

  • Cleveland Medical Devices Inc. has announced that the company's SleepView Direct service has been recognized in an article published in Sleep Review Magazine. This improved the company's product's ability to reach a large number of customers worldwide.
  • Oventus Medical has entered into a partnership agreement with Aeroflow Healthcare to bring Oventus' obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers in the United States through sleep clinics.

Explore wide-ranging Coverage of FMI's Healthcare Market Insights Landscape

Body Fat Reduction Market – The body fat reduction market size exceeded USD 9 billion in 2021 and is expected to register over 9.9% CAGR between 2022 and 2028. 

In Vitro Diagnostics Market – During the forecast period, the sales of in-vitro diagnostics hold an average growth prospect with an anticipated CAGR of 3% CAGR to reach a valuation of US$ 113 Bn by 2026, from US$ 98.2 Bn in 2021.

Companion Animal Drugs Market – Expanding at a CAGR of 5%, the global companion animal drugs market is projected to increase from a valuation of US$ 36.94 Bn in 2022 to US$ 47.23 Bn by the end of 2027.

Mobile Sterile Units Market – Demand in the mobile sterile units market is expected to increase by 5.5% CAGR from 2021 to 2031. In 2021, the market stood at US$ 205.4 Mn.

Telehealth and Telemedicine Market – The telehealth and telemedicine market is projected to attain a CAGR of 24.2% during the forecast period, up from US$ 87 Bn in 2022, to reach a valuation of US$ 285 Bn by 2027.  

Aromatherapy Market – The global aromatherapy market is currently valued at around US$ 5.9 Bn, and is anticipated to surge ahead at a CAGR of 8.1% to reach a market value of US$ 8.06 Bn by the end of 2026.

Dialyzer Reprocessing Machines and Concentrates Market – In 2022, the global dialyzer reprocessing machines and concentrates market is set to be worth US$ 1.2 Bn, and is predicted to attain a valuation of US$ 1.6 Bn by the end of 2028. Demand for dialyzer reprocessing machines and concentrates is projected to rise at a CAGR of 5.1% from 2022 to 2028.

Multi-Parameter Patient Monitoring Market –  The global multi-parameter patient monitoring market accounted for revenue worth US$ 4.6 Bn in 2022, and is projected to reach a valuation of US$ 6.1 Bn by 2028. Demand for multi-parameter patient monitors is anticipated to increase at a CAGR of 4.6% (2022-2028).

Deflectable Catheters Market – The global deflectable catheters market is projected to expand at a CAGR of 3.9% from 2022 to 2029. Sales of deflectable catheters currently stand at a valuation of US$ 1.8 Bn, and are estimated to reach a market valuation of US$ 2.4 Bn by 2029.

Oxytocin Market - Global Oxytocin market are set to experience a significant growth of 9.0% CAGR from 2022 to 2030, with an estimated market value of around US$ 83.0 Mn as of 2022. As per Future Market Insights’ projections, Postpartum type holds a substantial share of over 88.8%  in 2021 within the Global market.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.  

Contact:

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com/

Report: https://www.futuremarketinsights.com/reports/sleep-apnea-devices-market